Black Hawk Acquisition Corporation Class A Ordinary Shares
BKHAStock
$11.96+10.35%52W
Market Cap$49.68M
P/E37.36x
Div yield—
Beta0.12
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-4.01%
Price vs S&P 500 (4W)1.33%
VGM Score35.30
Market Capitalization$49.68M
P/E Ratio (Annual)37.36x
Industry Peers — Biological Products(180)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
BKHABlack Hawk Acquisition Corporation Class A Ordinary Shares | — | F | C | $11.96 |
| AMGNAmgen Inc | C | C | C | $371.58 |
| GILDGilead Sciences Inc | C | B | C | $136.30 |
| ARGXargenx SE American Depositary Shares | D | A | B | $857.97 |
| RVMDRevolution Medicines, Inc. Common Stock | F | — | A | $179.18 |
| BIIBBiogen Inc. Common Stock | B | D | B | $208.92 |
| BNTXBioNTech SE American Depositary Share | C | C | C | $91.56 |
| MRNAModerna, Inc. Common Stock | D | B | B | $63.15 |
| NBIXNeurocrine Biosciences Inc | C | B | B | $171.55 |
| EXELExelixis Inc | C | B | B | $55.68 |
| TECHBio-Techne Corp. | D | C | B | $71.77 |
About
Black Hawk Acquisition Corp is a special purpose acquisition company (SPAC) formed to acquire or merge with an operating business. The company seeks to create shareholder value through the identification and completion of a business combination with a suitable target enterprise.